Annual Net Income
-$135.12 M
+$144.70 M+51.71%
31 December 2023
Summary:
Inovio Pharmaceuticals annual net profit is currently -$135.12 million, with the most recent change of +$144.70 million (+51.71%) on 31 December 2023. During the last 3 years, it has risen by +$31.29 million (+18.81%). INO annual net income is now -2796.47% below its all-time high of -$4.66 million, reached on 31 December 2003.INO Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$25.17 M
+$7.07 M+21.94%
30 September 2024
Summary:
Inovio Pharmaceuticals quarterly net profit is currently -$25.17 million, with the most recent change of +$7.07 million (+21.94%) on 30 September 2024. Over the past year, it has increased by +$8.76 million (+25.83%). INO quarterly net income is now -231.27% below its all-time high of $19.17 million, reached on 30 September 2020.INO Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$112.88 M
+$8.76 M+7.21%
30 September 2024
Summary:
Inovio Pharmaceuticals TTM net profit is currently -$112.88 million, with the most recent change of +$8.76 million (+7.21%) on 30 September 2024. Over the past year, it has increased by +$51.70 million (+31.41%). INO TTM net income is now -11387.61% below its all-time high of $1.00 million, reached on 31 December 1998.INO TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INO Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +51.7% | +25.8% | +31.4% |
| 3 y3 years | +18.8% | +58.2% | +48.9% |
| 5 y5 years | -39.3% | -9.0% | +1.6% |
INO Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +55.5% | -0.7% | +76.8% | at high | +68.2% |
| 5 y | 5 years | -39.3% | +55.5% | -231.3% | +80.5% | at high | +68.2% |
| alltime | all time | -2796.5% | +55.5% | -231.3% | +80.5% | <-9999.0% | +68.2% |
Inovio Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$25.17 M(-21.9%) | -$112.88 M(-7.2%) |
| June 2024 | - | -$32.24 M(+5.8%) | -$121.64 M(-2.6%) |
| Mar 2024 | - | -$30.47 M(+21.9%) | -$124.94 M(-7.5%) |
| Dec 2023 | -$135.12 M(-51.7%) | -$25.00 M(-26.3%) | -$135.12 M(-17.9%) |
| Sept 2023 | - | -$33.93 M(-4.5%) | -$164.58 M(-2.3%) |
| June 2023 | - | -$35.53 M(-12.6%) | -$168.43 M(-30.2%) |
| Mar 2023 | - | -$40.65 M(-25.4%) | -$241.39 M(-13.7%) |
| Dec 2022 | -$279.82 M(-7.9%) | -$54.46 M(+44.1%) | -$279.82 M(-15.8%) |
| Sept 2022 | - | -$37.78 M(-65.2%) | -$332.30 M(-6.3%) |
| June 2022 | - | -$108.50 M(+37.2%) | -$354.69 M(+8.0%) |
| Mar 2022 | - | -$79.07 M(-26.1%) | -$328.33 M(+8.1%) |
| Dec 2021 | -$303.66 M(+82.5%) | -$106.95 M(+77.7%) | -$303.66 M(+37.4%) |
| Sept 2021 | - | -$60.17 M(-26.7%) | -$221.05 M(+56.0%) |
| June 2021 | - | -$82.14 M(+51.0%) | -$141.71 M(-24.7%) |
| Mar 2021 | - | -$54.40 M(+123.5%) | -$188.27 M(+13.1%) |
| Dec 2020 | -$166.41 M(+39.4%) | -$24.34 M(-227.0%) | -$166.41 M(-7.4%) |
| Sept 2020 | - | $19.17 M(-114.9%) | -$179.73 M(-19.0%) |
| June 2020 | - | -$128.70 M(+295.5%) | -$222.00 M(+81.0%) |
| Mar 2020 | - | -$32.54 M(-13.6%) | -$122.68 M(+2.8%) |
| Dec 2019 | -$119.36 M(+23.1%) | -$37.66 M(+63.1%) | -$119.36 M(+4.1%) |
| Sept 2019 | - | -$23.09 M(-21.4%) | -$114.66 M(-1.7%) |
| June 2019 | - | -$29.39 M(+0.6%) | -$116.58 M(+24.2%) |
| Mar 2019 | - | -$29.22 M(-11.4%) | -$93.84 M(-3.2%) |
| Dec 2018 | -$96.97 M(+9.9%) | -$32.96 M(+31.8%) | -$96.97 M(+13.4%) |
| Sept 2018 | - | -$25.02 M(+276.8%) | -$85.51 M(-9.6%) |
| June 2018 | - | -$6.64 M(-79.5%) | -$94.63 M(-2.9%) |
| Mar 2018 | - | -$32.35 M(+50.4%) | -$97.47 M(+10.5%) |
| Dec 2017 | -$88.21 M(+19.6%) | -$21.51 M(-37.0%) | -$88.21 M(-5.1%) |
| Sept 2017 | - | -$34.13 M(+260.1%) | -$92.93 M(+16.8%) |
| June 2017 | - | -$9.48 M(-58.9%) | -$79.56 M(-10.4%) |
| Mar 2017 | - | -$23.09 M(-12.0%) | -$88.78 M(+20.4%) |
| Dec 2016 | -$73.74 M(+152.6%) | -$26.23 M(+26.4%) | -$73.74 M(+12.7%) |
| Sept 2016 | - | -$20.76 M(+11.0%) | -$65.46 M(+67.4%) |
| June 2016 | - | -$18.70 M(+132.6%) | -$39.10 M(+46.7%) |
| Mar 2016 | - | -$8.04 M(-55.2%) | -$26.65 M(-8.7%) |
| Dec 2015 | -$29.19 M(-19.2%) | -$17.95 M(-420.9%) | -$29.19 M(+56.5%) |
| Sept 2015 | - | $5.59 M(-189.5%) | -$18.65 M(-40.7%) |
| June 2015 | - | -$6.25 M(-41.0%) | -$31.42 M(-12.4%) |
| Mar 2015 | - | -$10.58 M(+42.8%) | -$35.88 M(-0.7%) |
| Dec 2014 | -$36.12 M(-45.3%) | -$7.41 M(+3.3%) | -$36.12 M(-18.2%) |
| Sept 2014 | - | -$7.18 M(-33.0%) | -$44.16 M(-34.9%) |
| June 2014 | - | -$10.71 M(-1.0%) | -$67.86 M(-0.2%) |
| Mar 2014 | - | -$10.82 M(-30.0%) | -$68.01 M(+3.0%) |
| Dec 2013 | -$66.03 M(+235.7%) | -$15.45 M(-49.9%) | -$66.03 M(+28.9%) |
| Sept 2013 | - | -$30.88 M(+184.5%) | -$51.23 M(+89.9%) |
| June 2013 | - | -$10.85 M(+22.7%) | -$26.98 M(+33.2%) |
| Mar 2013 | - | -$8.84 M(+1242.5%) | -$20.26 M(+3.0%) |
| Dec 2012 | -$19.67 M(+29.0%) | -$658.80 K(-90.1%) | -$19.67 M(-19.7%) |
| Sept 2012 | - | -$6.62 M(+60.2%) | -$24.49 M(+9.3%) |
| June 2012 | - | -$4.13 M(-49.9%) | -$22.41 M(+6.2%) |
| Mar 2012 | - | -$8.25 M(+50.7%) | -$21.10 M(+38.3%) |
| Dec 2011 | -$15.25 M | -$5.48 M(+20.6%) | -$15.25 M(-5.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | -$4.54 M(+60.9%) | -$16.07 M(+24.2%) |
| June 2011 | - | -$2.82 M(+17.0%) | -$12.94 M(-27.0%) |
| Mar 2011 | - | -$2.41 M(-61.7%) | -$17.73 M(+0.7%) |
| Dec 2010 | -$17.61 M(-27.8%) | -$6.29 M(+346.3%) | -$17.61 M(-5.6%) |
| Sept 2010 | - | -$1.41 M(-81.5%) | -$18.67 M(-7.6%) |
| June 2010 | - | -$7.62 M(+232.1%) | -$20.20 M(-13.1%) |
| Mar 2010 | - | -$2.29 M(-68.8%) | -$23.24 M(-4.8%) |
| Dec 2009 | -$24.41 M(+88.3%) | -$7.35 M(+149.2%) | -$24.41 M(+18.3%) |
| Sept 2009 | - | -$2.95 M(-72.3%) | -$20.64 M(+3.0%) |
| June 2009 | - | -$10.65 M(+207.5%) | -$20.04 M(+49.4%) |
| Mar 2009 | - | -$3.46 M(-3.1%) | -$13.41 M(+3.4%) |
| Dec 2008 | -$12.97 M(+15.7%) | -$3.58 M(+52.5%) | -$12.97 M(+24.5%) |
| Sept 2008 | - | -$2.34 M(-41.7%) | -$10.42 M(-3.3%) |
| June 2008 | - | -$4.02 M(+33.2%) | -$10.77 M(+2.7%) |
| Mar 2008 | - | -$3.02 M(+194.5%) | -$10.48 M(-9.1%) |
| Dec 2007 | -$11.20 M(-9.2%) | -$1.03 M(-61.9%) | -$11.53 M(-16.2%) |
| Sept 2007 | - | -$2.69 M(-28.0%) | -$13.76 M(-4.9%) |
| June 2007 | - | -$3.74 M(-8.1%) | -$14.47 M(+5.0%) |
| Mar 2007 | - | -$4.07 M(+25.2%) | -$13.78 M(+11.6%) |
| Dec 2006 | -$12.34 M(-19.3%) | -$3.25 M(-4.6%) | -$12.34 M(+1.8%) |
| Sept 2006 | - | -$3.41 M(+11.8%) | -$12.13 M(+3.6%) |
| June 2006 | - | -$3.05 M(+15.8%) | -$11.71 M(+8.5%) |
| Mar 2006 | - | -$2.63 M(-13.2%) | -$10.79 M(-29.5%) |
| Dec 2005 | -$15.30 M(+39.4%) | -$3.04 M(+1.5%) | -$15.30 M(-4.7%) |
| Sept 2005 | - | -$2.99 M(+40.3%) | -$16.06 M(-2.7%) |
| June 2005 | - | -$2.13 M(-70.2%) | -$16.50 M(-0.2%) |
| Mar 2005 | - | -$7.14 M(+88.2%) | -$16.53 M(+50.7%) |
| Dec 2004 | -$10.97 M(+135.2%) | -$3.79 M(+10.6%) | -$10.97 M(+22.7%) |
| Sept 2004 | - | -$3.43 M(+58.5%) | -$8.94 M(+24.4%) |
| June 2004 | - | -$2.17 M(+36.9%) | -$7.19 M(+12.0%) |
| Mar 2004 | - | -$1.58 M(-10.4%) | -$6.42 M(+37.7%) |
| Dec 2003 | -$4.66 M(-21.8%) | -$1.77 M(+5.1%) | -$4.66 M(+4.3%) |
| Sept 2003 | - | -$1.68 M(+20.3%) | -$4.47 M(+6.9%) |
| June 2003 | - | -$1.40 M(-884.9%) | -$4.18 M(-3.2%) |
| Mar 2003 | - | $178.00 K(-111.3%) | -$4.33 M(-27.9%) |
| Dec 2002 | -$5.96 M(-6.2%) | -$1.57 M(+13.2%) | -$6.00 M(+35.6%) |
| Sept 2002 | - | -$1.39 M(-9.5%) | -$4.42 M(-6.8%) |
| June 2002 | - | -$1.54 M(+2.9%) | -$4.74 M(-19.4%) |
| Mar 2002 | - | -$1.49 M(-12.8%) | -$5.89 M(-37.7%) |
| Dec 2001 | -$6.36 M(-28.3%) | - | - |
| Sept 2001 | - | -$1.71 M(-36.2%) | -$9.45 M(-3.4%) |
| June 2001 | - | -$2.68 M(-7.4%) | -$9.79 M(-22.9%) |
| Mar 2001 | - | -$2.90 M(+34.1%) | -$12.70 M(+4.1%) |
| Mar 2001 | -$8.87 M(-7.6%) | - | - |
| Dec 2000 | - | -$2.16 M(+5.5%) | -$12.20 M(+1.3%) |
| Sept 2000 | - | -$2.05 M(-63.4%) | -$12.04 M(-1.6%) |
| June 2000 | - | -$5.60 M(+133.2%) | -$12.24 M(+28.2%) |
| Mar 2000 | -$9.60 M(+45.5%) | -$2.40 M(+20.0%) | -$9.54 M(-2.1%) |
| Dec 1999 | - | -$2.00 M(-10.9%) | -$9.74 M(+44.5%) |
| Sept 1999 | - | -$2.24 M(-22.6%) | -$6.74 M(+49.9%) |
| June 1999 | - | -$2.90 M(+11.5%) | -$4.50 M(+181.3%) |
| Mar 1999 | -$6.60 M | -$2.60 M(-360.0%) | -$1.60 M(-260.0%) |
| Dec 1998 | - | $1.00 M | $1.00 M |
FAQ
- What is Inovio Pharmaceuticals annual net profit?
- What is the all time high annual net income for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals annual net income year-on-year change?
- What is Inovio Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals quarterly net income year-on-year change?
- What is Inovio Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals TTM net income year-on-year change?
What is Inovio Pharmaceuticals annual net profit?
The current annual net income of INO is -$135.12 M
What is the all time high annual net income for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high annual net profit is -$4.66 M
What is Inovio Pharmaceuticals annual net income year-on-year change?
Over the past year, INO annual net profit has changed by +$144.70 M (+51.71%)
What is Inovio Pharmaceuticals quarterly net profit?
The current quarterly net income of INO is -$25.17 M
What is the all time high quarterly net income for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high quarterly net profit is $19.17 M
What is Inovio Pharmaceuticals quarterly net income year-on-year change?
Over the past year, INO quarterly net profit has changed by +$8.76 M (+25.83%)
What is Inovio Pharmaceuticals TTM net profit?
The current TTM net income of INO is -$112.88 M
What is the all time high TTM net income for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high TTM net profit is $1.00 M
What is Inovio Pharmaceuticals TTM net income year-on-year change?
Over the past year, INO TTM net profit has changed by +$51.70 M (+31.41%)